我要投票 采芝林在鹿茸行业中的票数:525
· 外 推 电 报 ·
2025-11-24 22:31:04 星期一

【采芝林是哪个国家的品牌?】

采芝林是什么牌子?「采芝林」是 广州白云山医药集团股份有限公司 旗下著名品牌。该品牌发源于广东,由创始人李楚源在1997-09-01期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力采芝林品牌出海!将品牌入驻外推网,定制采芝林品牌推广信息,可以显著提高采芝林产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

广州采芝林药业有限公司(原广州市药材公司)是广药集团属下广州白云山医药集团股份有限公司(香港H股、上海A股上市)的全资子公司,是一家集批发、零售和生产为一体的大型药品流通企业,也是国内领先的中药材经营企业,广东省500强企业,广药集团“大商业”板块核心成员单位,“十二五”期间年复合增长率达16%,远远高于医药行业平均增长速度,经营规模达50亿元。“采芝林”始创于公元1806年(清朝嘉庆十一年),至今已有200多年历史,是中药文化的集大成者和领航者,国家级“中华老字号”。

广州采芝林药业有限公司拥有以广东省为中心,辐射全国的中药材购销网络、网络商业调拨网络、零售连锁网络、医疗单位网络、电商网络等,并实现了中药材从原料采购到加工的一体化运作,产业链日趋完善,核心竞争能力与日俱增。旗下9个分公司遍布全国各地,分别为广州采芝林药业连锁店、广州采芝林北商药材有限公司、广州市药材公司中药饮片厂、广州澳马医疗器械有限公司、黑龙江森工广药中药材开发有限公司、山东广药中药材开发有限公司、乌兰察布广药中药材开发有限公司、靖宇县广药中药材开发有限公司和丰顺县广药中药材开发有限公司等。

英文翻译:Guangzhou Caizhilin Pharmaceutical Co., Ltd. (formerly Guangzhou herbal medicine company) is a wholly-owned subsidiary of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (listed in Hong Kong H share and Shanghai a share), a large pharmaceutical distribution enterprise integrating wholesale, retail and production. It is also a leading Chinese herbal medicine business enterprise in China, a top 500 enterprise in Guangdong Province, and a "big" enterprise of Guangzhou Pharmaceutical Group The core member of the business sector, with an annual compound growth rate of 16% during the 12th Five Year Plan period, is far higher than the average growth rate of the pharmaceutical industry, with a business scale of 5 billion yuan. Caizhilin was founded in 1806 A.D. (the 11th Jiaqing year of the Qing Dynasty). It has a history of more than 200 years. It is a master and navigator of traditional Chinese medicine culture and a national "time-honored brand of China". Guangzhou Caizhilin Pharmaceutical Co., Ltd. has a nationwide traditional Chinese medicine purchase and sale network, network commercial allocation network, retail chain network, medical unit network, e-commerce network, etc., with Guangdong Province as the center, and has realized the integrated operation of traditional Chinese medicine from raw material purchase to processing. The industrial chain is increasingly perfect, and the core competitiveness is growing day by day. Its nine branches are located all over the country, including Guangzhou Caizhilin pharmaceutical chain store, Guangzhou Caizhilin Beishang Pharmaceutical Co., Ltd., traditional Chinese medicine Yinpian factory of Guangzhou Pharmaceutical Company, Guangzhou AOMA Medical Equipment Co., Ltd., Heilongjiang Forest Industry Guangyao Chinese Medicine Development Co., Ltd., Shandong Guangyao Chinese Medicine Development Co., Ltd., Ulanchab Guangyao Chinese Medicine Development Co., Ltd., Jingyu County Guangyao Chinese herbal medicine development Co., Ltd. and Fengshun County Guangyao Chinese herbal medicine development Co., Ltd.

本文链接: https://www.waitui.com/brand/d0a191a17.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前普涨,谷歌涨超3%

36氪获悉,美股大型科技股盘前普涨,截至发稿,谷歌涨超3%,特斯拉涨超2%,Meta涨0.87%,亚马逊涨0.65%,英伟达涨0.5%,微软涨0.36%,苹果涨0.04%。

31分钟前

热门中概股美股盘前普涨,哔哩哔哩涨超6%

36氪获悉,热门中概股美股盘前普涨,截至发稿,哔哩哔哩涨超6%,百度、网易、蔚来涨超4%,小鹏汽车、阿里巴巴涨超3%,理想汽车、富途控股、爱奇艺、拼多多涨超1%。

31分钟前

美联储理事沃勒称他主张在12月降息

美联储理事沃勒称他主张在12月降息。并表示,9月份就业数据可能会被下修,数据集中出现并非好兆头;明年一月份将充满挑战,大量数据将陆续公布,以判断是否需要再次降息,美联储需要逐次会议地进行评估。(财联社)

31分钟前

新莱福:新莱福资管计划拟减持公司不超87.43万股股份

36氪获悉,新莱福发布公告,持股87.43万股,占公司总股本的0.83%的新莱福资管计划拟通过大宗交易或集中竞价交易方式减持公司股份不超过87.43万股,不超过公司总股本的0.83%,不超过剔除公司当前回购专用账户股份后总股本的0.84%。

32分钟前

明宇制药有限公司-B向港交所提交上市申请书

36氪获悉,明宇制药有限公司-B向港交所提交上市申请书,联席保荐人为Morgan Stanley,BofA Securities,CITIC Securities。

32分钟前

本页详细列出关于采芝林的品牌信息,含品牌所属公司介绍,采芝林所处行业的品牌地位及优势。
咨询